Multifunctional host defense peptides: functional and mechanistic insights from NMR structures of potent antimicrobial peptides by Bhattacharjya, Surajit & Ramamoorthy, Ayyalusamy
MINIREVIEW
Multifunctional host defense peptides: functional and
mechanistic insights from NMR structures of potent
antimicrobial peptides
Surajit Bhattacharjya1 and Ayyalusamy Ramamoorthy2
1 Biomolecular NMR and Drug Discovery Laboratory, School of Biological Sciences, Division of Structural and Computational Biology,
Nanyang Technological University, Singapore
2 Biophysics and Department of Chemistry, University of Michigan, Ann Arbor, MI, USA
Introduction
Bacterial resistance against commonly used antibiotics
such as penicillin, streptomycin, vancomycin and fluoro-
quinolones has been increasing at an alarming rate in
recent years [1,2]. The Infectious Diseases Society of
America reported that in the USA, about two million
people are acquiring bacterial infections every year, and
that 90 000 cases have fatal outcomes [3]. Currently,
bacterial strains isolated from hospital set up with resis-
tance against multiple antibiotics, termed as multidrug-
resistant (MDR) species, are the major cause of fatality.
Notably, multidrug-resistant strains have been reported
for a number of bacterial species, including Mycobacte-
rium tuberculosis, Enterococcus faecium, Klebsiella pneu-
moniae, Staphylococcus aureus, Pseudomonas aeruginosa
and Streptococcus pneumoniae from different parts of
the world [5,6]. Efforts to obtain a new generation of
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The ever-increasing number of drug-resistant bacteria is a major challenge
in healthcare and creates an urgent need for novel compounds for treat-
ment. Host defense antimicrobial peptides have high potential to become
the new generation of antibiotic compounds. Antimicrobial peptides consti-
tute a major part of the innate defense system in all life forms. Most of
these cationic amphipathic peptides are often unstructured in isolation but
readily adopt amphipathic helical structures in complex with lipid mem-
branes. Such structural stabilization is primarily responsible for the mem-
brane permeation and cell lysis activities of these molecules. Understanding
structure–function correlations of antimicrobial peptides is critical for the
development of nontoxic therapeutics. In this minireview, we discuss
atomic-resolution NMR structures of two highly potent helical antimicro-
bial peptides, MSI-78 and MSI-594, providing novel insights into their
mechanisms of action.
Abbreviations
LPS, lipopolysaccharide; POPC, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine; Tr-NOE, transferred-NOE.
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drugs using existing antibiotic scaffolds are often chal-
lenging, as a result of their inability to penetrate the
bacterial cell wall adequately. Therefore, there is a des-
perate need to identify new antimicrobial compounds.
In this scenario, host defense antimicrobial peptides
offer an attractive solution to the increasing bacterial
resistance problem, and have spurred considerable sci-
entific interest. Antimicrobial peptides, distributed in
all life forms, show broad-spectrum activities against
bacteria, fungi, and viruses [7–10]. Antimicrobial pep-
tides in multicellular organisms constitute an integral
part of the innate immune system, forming the first line
of defense against invading microbes. They are also
implicated in the stimulation and modulation of adap-
tive immunities [11,12]. On the basis of their structures,
antimicrobial peptides can be divided into three groups,
a-helical (e.g. cecropin and magainin), b-sheet or
b-hairpin, stabilized by disulfide bonds (e.g. defensins,
tachyplesins, and protegrins), and extended (e.g. indo-
licidin and PR-39) [13–15]. Although they are highly
diverse in amino acid sequences and structures, a com-
mon feature shared among the antimicrobial peptides is
the preponderance of positive charges (average +4 to
+6) and a high (40–60%) content of hydrophobic resi-
dues [16,17]. Unlike conventional antibiotics, which act
on specific intracellular targets, most of the antimicro-
bial peptides disrupt the structural integrity of cellular
membranes. The negatively charged phospholipids of
the membrane provide the initial binding sites for the
cationic antimicrobial peptides through electrostatic
interactions. Once anchored at the membrane surfaces,
antimicrobial peptides fold into amphipathic structures,
with one face of the peptide being hydrophobic and the
other face containing the cluster of positively charged
residues. Although acquisition of an amphipathic struc-
ture is a prerequisite for cell lysis, the exact mecha-
nism(s) are still debated. It has been thought that such
amphipathic structures might strongly interact with lip-
ids and self-associate to form pores into the membranes
or may disintegrate the membranes in a detergent-like
manner [13–15]. Determination of the structure of anti-
microbial peptides in appropriate lipid environments at
atomic-scale resolution is an essential step in under-
standing the mechanism of actions of the antimicrobial
peptides and development of nontoxic novel antibiotics.
Global structural information can be easily obtained by
use of CD, FTIR and fluorescence methods. However,
an atomic-resolution structure will generate useful
insights into antimicrobial peptide oligomerization
states, higher-order folding, and side chain–side chain
packing in complex with phospholipids. NMR, both
solution-state and solid-state, has been the key method
for obtaining structural determinants of a large number
of antimicrobial peptides of different structural classes
[18–20]. NMR structural studies on potent MSI-78 and
MSI-594 peptides are presented in the following sec-
tion. It should also be mentioned that there are other
antimicrobial peptides that do not have a specific
amphipathic structure, but are still very active.
Atomic-level 3D structures of potent
antimicrobial peptides in a membrane
environment obtained from NMR
studies
As the function of antimicrobial peptides is exerted at
the cell membrane interface, it is essential to solve their
structures in a biologically relevant membrane environ-
ment. At the same time, determining the high-resolu-
tion structure of membrane-associated peptides has
been a major challenge to most biophysical techniques.
Fortunately, recent NMR studies have shown that
atomic-level 3D structure, membrane orientation and
dynamics can be obtained by using a combination of
NMR techniques and model membranes. Detergent
micelles or near-isotropic bicelles are well suited for
solution NMR spectroscopy, as they tumble suffi-
ciently quickly to result in high-resolution spectral
lines. The negatively charged SDS micelle has been
considered to be a close mimic of the anionic lipid
membranes of bacterial cells, whereas the zwitterionic
dodecylphosphocholine (DPC) micelles could provide
an environment akin to mammalian cell membranes
[18–20]. As a complex of peptide and model lipid
membrane is immobile in the NMR time scale, solid-
state NMR techniques are used to determine the high-
resolution structure of antimicrobial peptides [12,21].
In addition, solid-state NMR methods have been used
to determine the orientation and dynamics of antimi-
crobial peptides in fluid membrane bilayers. Solid-state
NMR measurements with a varying membrane compo-
sition have been used to determine oligomerization
and the mechanism(s) of membrane permeation and
disruption [22].
Solution NMR experiments were used to determine
the 3D structures of antimicrobial peptides such as
MSI-78 [23], MSI-594 [23], pardaxin [20], LL-37 [18],
polyphemusin [19], and analogs of melittin [24]. These
studies have also determined the location of an antimi-
crobial peptide in micelles, using paramagnetic relaxa-
tion effects. Whereas most peptides exist as monomers
in micelles, MSI-78 (or pexiganan) and magainin-2
have been shown to exist as antiparallel helical dimers
located near the head group region of micelles. As
oligomerization is a key step in the antimicrobial activ-
ity of antimicrobial peptides, a recent study enhanced
Insights from NMR structures of antimicrobial peptides S. Bhattacharjya and A. Ramamoorthy
6466 FEBS Journal 276 (2009) 6465–6473 ª 2009 The Authors Journal compilation ª 2009 FEBS
the hydrophobicity of the dimeric helical interface by
substituting with fluorinated amino acids. The resul-
tant fluorinated MSI-78 (or fluorogainin) has been
shown to be more potent than the nonfluorinated
MSI-78 [25,26]. Vogel et al. have used high-resolution
solution NMR spectroscopy to determine the 3D
structures of antimicrobial peptides [27], and correlated
structures of antimicrobial peptides with their
functions [28].
A combination of static solid-state NMR experi-
ments on mechanically aligned lipid bilayers [29] and
magic angle spinning experiments on multilamellar
vesicles was used to determine the backbone conforma-
tion and the membrane orientation of MSI peptides.
Solid-state NMR experiments on lipid vesicles
confirmed the helical conformation of these peptides as
determined from solution NMR experiments on deter-
gent micelles. Two-dimensional polarization inversion
spin exchange at the magic angle [30,31] experiments on
mechanically aligned bilayers revealed the membrane
surface orientation of these peptides in lipid bilayers.
Multilamellar vesicles with varying membrane composi-
tion were investigated to understand the effect of indi-
vidual components on the structure and membrane
orientation of antimicrobial peptides [32,33]. For
example, samples with varying concentration ratios of
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC)
and 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1¢-sn-
glycerol) were used to determine the role of an anionic
lipid in mammalian cell membranes; 1-palmitoyl-2-
oleoyl-sn-glycero-3-phosphoethanolamine and 1-palmi-
toyl-2-oleoyl-sn-glycero-3-phospho-(1¢-sn-glycerol) were
used to determine the role of an anionic lipid in bacte-
rial cell (inner) membranes; POPC and cholesterol
were used to determine the role of cholesterol in
mammalian cell membranes; and 1,2-dimyristoyl-sn-
glycero-3-phosphocholine and 1,2-dimyristoyl-sn-glycero-
3-phospho-(1¢-rac-glycerol) were used to investigate
the role of hydrophobic thickness of the membrane
bilayer. Rotational echo double resonance [34] magic
angle spinning experiments suggested that the back-
bone helical conformation of MSI peptides does not
depend on the variation in the membrane composition.
Two-dimensional polarization inversion spin exchange
at the magic angle experiments on mechanically
aligned samples revealed that the membrane orienta-
tions of both MSI-78 and MSI-594 peptides do not
vary within experimental errors with most of the
above-mentioned samples [32]. Both peptides were sta-
bilized by the lipid–peptide interactions near the head
group region of the bilayer, with the helical axis nearly
parallel to the bilayer surface. Interestingly, the tilt of
the MSI-594 helix varied from 15 to 25 from the
bilayer surface, whereas that of the MSI-78 helix var-
ied from 5 to 10. The difference in the tilt angle
between these two peptides could be due to the differ-
ence in their oligomeric size: MSI-78 is a dimer and
MSI-594 is a monomer [23]. The peptide–peptide inter-
action in MSI-78 could dominate and lead to a stabi-
lized membrane orientation without the need for
insertion into the hydrophobic region of the bilayer.
On the other hand, the presence of cholesterol reduced
the tilt of the MSI-594 helix to within 5 and that of
the MSI-78 peptide to < 5. This observation on the
reduction in the tilt angle could be attributed to the
cholesterol-induced ordering of the lipid bilayer, which
considerably reduces the peptide insertion into the
hydrophobic area of the lipid bilayer. Our solid-state
NMR studies indicated that the membrane orienta-
tions of MSI and LL-37 [35,36] peptides do not signifi-
cantly change with the hydrophobic thickness of the
lipid bilayer; the membrane orientation of pardaxin
was found to change from the transmembrane orienta-
tion in the thinner 1,2-dimyristoyl-sn-glycero-3-phos-
phocholine bilayer to an orientation with its main
helical axis close to the thicker POPC bilayer surface
[20]. Other solid-state NMR studies on peptide starting
with a glycine and ending with a leucine amide (PGLa)
have reported a change in the membrane orientation
of the peptide due to oligomerization [37]. Such high-
resolution information on the membrane orientation of
antimicrobial peptides provides insights into their
mechanism and will also aid in the design of more
potent antimicrobial peptides.
Various combinations of solid-state NMR experi-
ments were used to determine the peptide-induced
membrane permeation and disruption for these pep-
tides [21,32,36–39]. Peptide-induced effects such as (a)
the disorder in the lipid head group region of lipids,
(b) change in the lipid head group conformation, (c)
membrane curvature and (d) disorder in the hydropho-
bic region of bilayers were measured from fluid lipid
bilayers with various membrane compositions under
physiologically relevant experimental conditions. Both
high-resolution spectra of aligned bilayers and powder
pattern spectral line shapes of unaligned samples were
used in these experiments. All MSI (MSI-78, MSI-594,
and MSI-843) [32,40] and LL-37 [12,36] peptides were
found to disrupt the membrane via carpet mechanisms
at low concentrations. MSI peptides led to the forma-
tion of toroidal-type pores, whose geometry, as deter-
mined from solid-state NMR experiments, was also
reported [32]. Interestingly, these MSI peptides also
behaved like a detergent, and, after a certain time
( 3 weeks), induced the formation of bicelles that
spontaneously aligned in the magnetic field. Finally,
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after 1 month, these samples consisted of micelles, as
detected by the presence of isotropic 31P chemical
shifts [21,41]. Solid-state NMR experiments on bicelles
revealed the detergent-like behavior of MSI-78 and
functional peptide fragments of human b-defensin-3,
as they preferred to be associated with the toroidal
pores of bicelles.
Structures and mechanisms of
antimicrobial peptides in a model
outer membrane of bacteria
In addition to the inner phospholipid membrane,
Gram-negative bacteria contain an outer mem-
brane that acts as a permeability barrier against
hydrophobic antibiotics, host defense antimicrobial
peptides, and other detergent molecules [42–44]. The
outer leaflet of the outer membrane consists of a spe-
cialized lipid called lipopolysaccharide (LPS). Chemi-
cally, LPS is organized into three distinct regions: a
hydrophobic lipid A region, a variable polysaccharide
moiety or O-antigen, and the core oligosaccharide
region that covalently bridges the two [44]. The
lipid A region is highly conserved among Gram-nega-
tive bacteria, and consists of a bis-phosphorylated
diglucosamine backbone containing six to seven fatty
acyl chains per molecule [44,45]. In order to gain
access to the inner membrane or to the intracellular
targets, antimicrobial peptides have to interact with
the LPS layer. Recent studies have suggested that
LPS is actively involved in controlling the binding
and permeation of antimicrobial peptides into Gram-
negative organisms [46–49]. Structures of antimicro-
bial peptides derived from model membranes
composed of synthetic lipids often show poor correla-
tion with their functions. Interactions of the anti-
microbial peptides with LPS could constitute one of
the determining factors. Moreover, LPS or endotoxin,
a potent stimulator of innate immune systems, is the
primary agent of septic shock syndromes [50,51].
Therefore, determination of structures of antimicro-
bial peptides in the context of LPS would be an
important step towards understanding the mechanism
of outer membrane permeabilization and the develop-
ment of endotoxin-neutralizing molecules. We have
determined 3D structures of antimicrobial peptides
and designed peptides in complex with LPS, using
NMR experiments, to gain insights into the peptide
interactions with LPS [52–57]. LPS-bound structures
of peptides and antimicrobial peptides are determined
using transferred-NOE (Tr-NOE) effect spectroscopy.
In the Tr-NOE method, NOEs from the bound
ligands are observed in their free-state resonances,
whereas ligand–macromolecule complexes undergo
fast dissociation on the NMR time scale. Usually, Tr-
NOE-based structure determination is applicable to
macromolecule–ligand complexes with binding affini-
ties ranging from micromolar to millimolar. Tr-NOE
of LPS-bound peptide was first demonstrated in an
analog of polymyxin B [58]. Since then, the method
has met with notable successes in determining 3D
structures of LPS-interacting peptides [59–61]. LPS
forms large molecular mass micelles or bilayers in
solutions at a significantly lower (£ 1 lm) concentra-
tion [62]. The larger size of LPS micelles, coupled
with rapid dissociation of LPS–peptide complexes,
may generate a large number of Tr-NOE cross-peaks
for the bound peptides. High-resolution structures of
the LPS-bound states of peptides are determined on
the basis of the distance constraints obtained from
Tr-NOE analyses [52–57]. LPS, being a lipid of the
outer membrane, provides a native environment for
the folding of the peptides and antimicrobial peptides.
In conjunction with Tr-NOE, we have employed a
saturation transfer difference NMR method [63] to
determine the proximity or localization of several
antimicrobial and cytotoxic peptides in LPS micelles
at residue-specific details [53,55,56].
Recently, the LPS-bound structure of the highly
potent antimicrobial peptide MSI-594 was determined
by us [56]. The 3D structure determination of MSI-594
in complex with LPS reveals a helix–loop–helix or a
helical hairpin structure (Fig. 1A). The solution struc-
ture of MSI-594 in complex with LPS is determined by
two segments of helices, Ile2–Lys10 and Ile13–Leu24,
with an intervening loop maintained by two Gly
residues (Fig. 1A). The two helices are stabilized by
mutual packing interactions whereby the single aro-
matic residue Phe5 is found to be in proximity with a
number of nonpolar residues, Ile2, Ile13, Leu17, and
Leu20 (Fig. 1B) [56]. Determination of the LPS-bound
structure of MSI-594 showed that all of its five posi-
tively charged Lys residues are situated at one face of
the molecule and that nonpolar residues occupy the
opposite surface (Fig. 1C). The saturation transfer dif-
ference NMR studies revealed that the aromatic ring
of Phe5 and side chain methyl groups of Ile and Leu
are in close contact with LPS. MSI-594 possesses a
parallel orientation in LPS micelles, as inferred from
the nitro oxide spin-labeled measurements. Interest-
ingly, the NMR structure of MSI-594 derived from
DPC micelles showed a straight helix without any
long-range packing as observed in LPS. Therefore, it is
likely that antimicrobial peptides could have different
structural organizations at the outer membrane [53,56].
Such compact conformations may essentially help the
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peptides to translocate across the LPS bilayer (Fig. 2).
A different mechanism may have been utilized by
melittin, a hemolytic peptide from bee venom, to over-
come the LPS barrier. Melittin adopted a partial heli-
cal structure restricted to the cationic C-terminus of
the molecule in LPS micelles [53]. The relatively hydro-
phobic N-terminus of melittin was found to be
unstructured and dynamic in LPS. It is likely that the
folded C-terminus of melittin acts as an anchoring ele-
ment and perturb LPS structures, enabling insertion of
the hydrophobic N-terminus towards the inner mem-
brane (Fig. 3). Our research shows not only helical
conformations, but also that peptides may form
b-strands and b-turn structures in LPS micelles
[52,54,57]. With a set of designed peptides, the
LPS-bound structures reveal multiple b-turn and
b-strand structures (Fig. 4) of these antimicrobial and
antiendotoxic peptides [51,53,57].
Our recent studies show that disruption of interheli-
cal packing by mutating Phe5 of MSI-594 to Ala has
severe consequences for the antimicrobial activity of
MSI-594 (our unpublished result). These results clearly




Fig. 1. Three-dimensional structure of MSI-594 in LPS. (A) The
helix–turn–helix organization of the peptide, showing backbone and
side chain orientation. (B) Space-filling representation of the interhe-
lical interactions whereby aromatic residue Phe5 undergoes inti-
mate packing with nonpolar residues Ile13, Leu17 and Leu20 from
the long helix. (C) Unique disposition of the positively charged side
chains of MSI-594 in the amphipathic helical hairpin structure. A
13 Å distance between the charged groups geometrically comple-
ments interphosphate distance of the lipid A moiety of LPS. The
figure was generated using PYMOL (Protein Data Bank: 2K98).
Fig. 2. A proposed model for the mechanism of permeation of
MSI-594 through the LPS layer. Top panel: free MSI-594 is unstruc-
tured in solution. Middle panel: peptide binds to the LPS surface
via electrostatic interactions, as charge and geometrical compatibil-
ity facilitate optimal adsorption; upon binding to LPS, MSI-594 folds
into a compact helical hairpin structure, secluding some of the non-
polar residues. Bottom panel: binding could lead to further destabili-
zation or perturbation of the LPS layer, whereby the peptide in its
compact state may easily translocate towards the inner cell
membrane.
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microbial peptides requires knowledge of interactions
of peptides with outer membranes. In addition, NMR
structure and dynamics have been reported for iso-
tope-labeled (15N ⁄ 13C) LPS solublized in detergent
micelles [64,65]. Another study determined the binding
sites of LPS in the presence of polymyxin antibiotic
peptides, using DPC-solublized isotope-labeled LPS
[66].
Remaining challenges
In order to form pores and disintegrate membrane
components (inner and outer), the antimicrobial peptides
might be required to form oligomeric assemblages.
However, high-resolution structures of such higher-order
states of antimicrobial peptides are not easily obtain-
able. MSI-78 and magainin showed a dimeric structure
in DPC micelles and lipid vesicles, respectively. It is
likely that currently used detergent micelles, SDS or
DPC, may not stabilize such oligomeric structures. In
particular, SDS is not known to disrupt noncovalent
interactions in proteins. Therefore, alternative lipid
environments need to be developed. Currently, small
bicelles, containing a mixture of long-chain and short-
chain phospholipids, are thought to constitute a close
mimic of the bilayer of cell membranes [67–69]. Bicelles
have been demonstrated to constitute a suitable med-
ium for structural analysis of membrane proteins by
NMR spectroscopy [68–71]. Larger bicelles have been
found to be useful for solid-state NMR as an alignment
medium [72,73]. Antimicrobial peptide studies in such
lipid environments may prove to be useful for the
determination of oligomeric structures. The presence of
toroidal pores in lamellar-phase bicelles could be
utilized in determining the mechanism of membrane
disruption by antimicrobial peptides [73]. On the other
hand, the LPS micelle has been shown to be a promis-
ing lipid system for the outer membrane that stabilizes
not only secondary structures but also tertiary packing
in antimicrobial peptides [56,57,60]. Even more
recently, we were able to determine an oligomeric struc-
ture of an antimicrobial peptide belonging to the cath-
elicidin family from the chicken in LPS (Bhattacharjya,
unpublished results). However, not all antimicrobial
peptides will produce Tr-NOE in LPS, as a result of
binding heterogeneity. Therefore, future studies on
antimicrobial peptides and LPS will require the prepa-
ration of suitable outer membrane mimics. It will be
interesting to see whether bicelles can be made using
LPS and other short-chain phospholipids. It would also
be interesting to investigate the intracellular action of
certain antimicrobial peptides [74] using high-resolution
NMR techniques.
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Fig. 3. Interactions of melittin with LPS. The bee venom peptide
folds into a helical structure at its C-terminus in complex with LPS.
The four positively charged residues, Lys21, Arg22, Lys23 and
Arg24, at the C-terminus may stabilize the helical structure by
inserting between two LPS molecules. The dynamic nonpolar
N-terminus may drive the translocation of the peptide across the
LPS layer. The figure was prepared using the INSIGHT II molecular
modeling program.
Fig. 4. Structure of a designed peptide in LPS. The designed pep-
tide adopts multiple b-turns at the C-terminus, whereas the N-ter-
minus has a b-strand-type structure. The plausible short-range and
long-range hydrogen bonds stabilizing the folded structure are
shown as solid and dotted lines, respectively. The figure was pre-
pared using the INSIGHT II molecular modeling program (Protein Data
Bank: 2o0S).
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